ImmunoTargets and Therapy
Volume 12, 2023 - Issue
Open access
80
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT
Extended-Release Tofacitinib Therapy for a MDA5 Antibody-Positive Amyopathic Dermatomyositis Patient with Early-Stage Interstitial Lung Disease
Chrong-Reen Wang1 Division of Rheumatology and Immunology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, TaiwanCorrespondence[email protected]
https://orcid.org/0000-0001-9881-7024View further author information
Wei-Chieh Lin2 Division of Critical Care Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, TaiwanView further author information
& Tak-Wah Wong3 Department of Dermatology, National Cheng Kung University Hospital, Tainan, Taiwan
https://orcid.org/0000-0002-0131-7339View further author information
Pages 187-192
|
Received 23 Oct 2023, Accepted 13 Dec 2023, Published online: 19 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.